Active Ingredient: MORPHINE SULFATE
Proprietary Name: MITIGO
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 10MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A204393
Product Number: 001
Approval Date: Jul 16, 2018
Applicant Holder Full Name: PIRAMAL CRITICAL CARE INC
Marketing Status:
Prescription
Patent and Exclusivity Information
